Conference call to review new interim data from Phase 2 Advanced-2 Trial of TARA-002 in patients with NMIBC will be held on December 5 at 8:30 am. Webcast Link
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TARA: